|Articles|June 1, 2019
- Pharmaceutical Executive-06-01-2019
- Volume 39
- Issue 6
Pharmaceutical Executive, June 2019 Issue (PDF)
Click the title above to open the Pharmaceutical Executive June 2019 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 7 years ago
Pharm Exec's Top 50 Companies 2019about 7 years ago
The Argument for External Comparator Adoptionabout 7 years ago
Pharma Medical Affairs: A Blueprint for Futureabout 7 years ago
'Vision’ Quest: Leading Through Changeabout 7 years ago
Pharm Exec 50 Hints to Rest of ’19about 7 years ago
Predicting the Future of European Health Policyabout 7 years ago
A Critical Juncture for Antibiotic R&Dabout 7 years ago
New Strategies Sought to Pay for Costly Curesover 7 years ago
Site Payments: Drilling in on Forecast, Budget Issuesover 7 years ago
Building the Startup Dream TeamAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Novartis, Bristol Myers Pause Autoimmune CAR-T Trials Over Safety Concerns: Report
2
FDA Approves Zanvastro for Alexander Disease in Pediatrics & Adults
3
Ultragenyx Shares Drop Following Failed Phase III Clinical Trial
4
Pharmaceutical Executive Daily: FDA Approves Zanvastro
5